Alkem Laboratories · NSE: ALKEM · BSE: 539523
Q3 FY23 results · Oct–Dec 2022
Alkem Laboratories reported revenue from operations of ₹3,040.91 crore (up 16.1% from Q3 FY22) and net profit of ₹459.96 crore (down 13.8% from Q3 FY22) for Q3 FY23 (Oct–Dec 2022), on a consolidated basis.
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 3,040.91 | 2,618.98 | +16.1% | 3,079.37 | −1.2% |
| Other income | 45.33 | 53.52 | −15.3% | 50.67 | −10.5% |
| Total income | 3,086.24 | 2,672.50 | +15.5% | 3,130.04 | −1.4% |
| Profit before tax | 538.89 | 463.94 | +16.2% | 402.33 | +33.9% |
| Net profit for the period | 459.96 | 533.35 | −13.8% | 347.72 | +32.3% |
| Attributable to shareholders of the company | 454.71 | 525.66 | −13.5% | 330.84 | +37.4% |
| EPS, basic (₹) | 38.03 | 43.96 | −13.5% | 27.67 | +37.4% |
| Net margin (%) | 15.1 | 20.4 | 11.3 |
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2,296.72 | 2,180.84 | +5.3% | 2,461.49 | −6.7% |
| Other income | 60.74 | 63.24 | −4.0% | 73.64 | −17.5% |
| Total income | 2,357.46 | 2,244.08 | +5.1% | 2,535.13 | −7.0% |
| Profit before tax | 435.95 | 469.81 | −7.2% | 401.56 | +8.6% |
| Net profit for the period | 388.89 | 437.09 | −11.0% | 350.69 | +10.9% |
| EPS, basic (₹) | 32.52 | 36.56 | −11.0% | 29.33 | +10.9% |
| Net margin (%) | 16.9 | 20.0 | 14.2 |
Consolidated
- Filed with BSE
- 10 Feb 2023, 17:39 IST
- Board meeting
- 10 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 10 Feb 2023, 17:39 IST
- Board meeting
- 10 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE